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The nuclear hormone receptors are attractive drug targets because they regulate major (patho)physiological processes and
their ligands are convenient for chemical synthesis. Importantly, subtle changes in the structure of a ligand can direct the
activity towards a particular receptor subtype and various types of functional specifications, such as agonism/antagonism,
(hetero)dimer selectivity, or cell/pathway selectivity. Germain et al. reveal here structural insight into the differential interaction
with coregulators, which accounts for very different functionalities of several antagonistic retinoids. As coregulators act as
platforms to assemble complexes with epigenetic activities, such ligands can be used to differentially regulate RAR-mediated
gene programs.
Lantibiotic Mersacidin under Scalpel
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Lantibiotics are a class of antibacterial compounds with activity against Gram-posi-
tive pathogens. Due to the biosynthetic origin of lantibiotics, the manipulation of the
peptide backbone in this class is particularly amenable to engineering. Appleyard
et al. show that it is possible to develop efficient systems for manipulation of this
type of molecule. A library of Mersacidin variants was generated and compounds
with improved antibacterial potency were obtained, opening up the possibility of
using this type of methodology for further improvements in the properties of this
class of compounds and providing useful information regarding the flexibility of
this biosynthetic pathway. (Figure credits: Appleyard et al.)
Magic Bullet Hits Multiple Targets
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Mycobacterium tuberculosis remains a major global health problem increasingly
characterized by antibiotic resistance. In this work, Barkan et al. identify and validate
a new target for antimicrobial development inM. tuberculosis. The major lipids of the
cell wall, mycolic acids, are modified with cyclopropane rings by a family of methyl-
transferases. Barkan et al. show here that inhibition of this entire methyltransferase
family by a single compound produces cell death and synergy with existing antimycobacterials. In addition to identifying
a new antibiotic strategy for M. tuberculosis, these findings establish that a family of homologous enzymes can be targeted
by a single compound, expanding the common conception of the inhibitor-target relationship.
New Functions for Old Enzymes
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Mycolic acids are major and specific lipids of theMycobacterium tuberculosis cell envelope. Understanding the biosynthesis
of these critical components is an important goal toward the design of new antituberculosis therapetutics. FadD32, a fatty
acyl-AMP ligase (FAAL), activates C50-C60 fatty acids to be condensed with C22-C26 acids to yield mycolic acids. The present
work by Le´ger et al. reveals the acyl-ACP ligase function of FadD32, in addition to its recognized FAAL activity. FadD32 may
thus be the prototype of a group of M. tuberculosis polyketide-synthase-associated adenylation enzymes possessing such
activity. A FadD32 substrate analog inhibited the enzyme activity, mycolic acid synthesis, and mycobacterial growth.
DF508-CFTR Getting Sorted Out
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Themajor cystic-fibrosis-causing mutation deltaF508-CFTR
leads to misfolding and mistrafficking of the protein with
retention in the endoplasmic reticulum (ER). In the current
study, Kim Chiaw et al. introduce a peptide-based approach
that targets an endogenous di-arginine ER retention motif
that becomes aberrantly exposed in DF508-CFTR. Our
results suggest that a particular di-arginine motif proximal
to the signature motif in NBD1 may contribute to retention
of DF508-CFTR. More importantly, the retention conferred
by this particular motif in situ can be overcome using
a peptide-based approach. This structural feature may
thus comprise a molecular target for effective cystic fibrosis
therapies.Chemistry & Biology 16, May 29, 2009 ª2009 Elsevier Ltd All rights reserved ix
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Heritable mutations in tRNA synthetases are causally linked to disease. While aminoacyl-tRNA synthetases are universal
proteins known for catalysis of aminoacylation, the later-developed expanded functions of many mammalian synthetases
in cytokine signaling and regulatory pathways are considered to be the main connection with diseases. The work by Kapoor
et al. shows that the ancient conserved architecture of tRNA synthetases can protect the essential aminoacylation function
when new cell-signaling epitopes are introduced near the catalytic site. Consequently, because of the protective isolation of
the active site, disease-causing mutations that affect only cell signaling can arise and be transmitted.
Mechanistic Diversity of Class D Carbapenemases
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Class D carbapenemases hydrolyze last-generation b-lactam
antibiotics, the carbapenems. Docquier et al. compared the
crystal structure of OXA-48 with available b-lactamase struc-
tures. Surprisingly, the structure of OXA-48 was similar to
that of OXA-10, an enzyme devoid of carbapenemase activity,
indicating that the hydrolysis of these compounds could
depend on subtle changes in the active-site region. Moreover,
the active-site groove of OXA-48 was different from that of
OXA-24 (another carbapenemase). Molecular dynamics
pointed to the functional relevance of residues located in or
close to the b5-b6 loop and allowed the authors to propose
a mechanism for carbapenem hydrolysis by OXA-48. (Figure-
credit: Docquier et al.)
Bacterial Cell Wall Crumbling Down
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This report by D’Elia et al. describes surprising genetic
connectivity among three vital processes in Gram-positive
bacteria, namely isoprenoid, peptidoglycan, and wall teichoic acid biogenesis. This connectivity was revealed with a library
of small-molecule probes of bacterial physiology and follows in the wake of recent studies revealing a paradox in teichoic acid
synthesis. Enzymes acting early in teichoic acid synthesis are now understood to be dispensable for cell viability, suggesting
that the polymer itself is expendable, while the loss of late-acting pathway enzymes is lethal. These latest findings open the
door for strategies to exploit these complex genetic interactions for new antibiotic discovery.
Tau Pre-mRNA SRE in the Grips of Mitoxantrone
PAGE 557
Destabilization of an RNA regulatory element by mutations observed in patients alters pre-
mRNA splicing of tau protein and causes familiar forms of neurodegenerative diseases.
Since stabilizing the RNA by single-nucleotide changes reverses the splicing pattern,
a small molecule that stabilizes this RNA could potentially be a drug candidate. Here,
Zheng et al. report the structure of the RNA-splicing regulatory element bound to such
a stabilizingmolecule, the anticancer drugmitoxantrone. This structure provides a rationale
to optimize the activity of this class of compounds and sheds light on the general mecha-
nism of the interaction of mitoxantrone with nucleic acids.
Alternative Epimerization Catalyzed by a Member
of VOC Superfamily
PAGE 567
Exemplified by antidiabetic acarbose and antifungal validamycin, C7N-aminocyclitols all
share a valienamine moiety, which is essential for the biological activities and whose
biosynthesis requires an epimerization reaction. In this issue, Xu et al. characterized an
epimerase ValD genetically and biochemically from a validamycin biosynthetic pathway.
ValD converted 2-epi-5-epi-valiolone to 5-epi-valiolone, representing an alternative epime-
rization for C7N-aminocyclitol biosynthesis. It is also confirmed to be a giant dimeric metal-
loenzyme of the vicinal oxygen chelate (VOC) superfamily, with strong metal-binding
capacity. The data presented here intensified the diversity of C7N-aminocyclitol biosyn-
thesis and displayed pathway engineering potential for generating improved C7N-amino-
cyclitol derivatives.x Chemistry & Biology 16, May 29, 2009 ª2009 Elsevier Ltd All rights reserved
